Literature DB >> 11331343

Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer?

M S Copur, P Ledakis, M Bolton, M Norvell, J Muhvic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11331343

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.

Authors:  G Ferretti; E Bria; D Giannarelli; A Felici; P Papaldo; A Fabi; S Di Cosimo; E M Ruggeri; M Milella; M Ciccarese; F L Cecere; A Gelibter; C Nuzzo; F Cognetti; E Terzoli; P Carlini
Journal:  Br J Cancer       Date:  2006-05-30       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.